good position, page-11

At least we should know more news this time next week.

With the amount of research I have done on this one, I'll be sticking around regardless of the outcome. I have full confidence in the company, and the product development.
It won't surprise me to see a move to further intensive testing.
From memory, this one is in vitro yes? Maybe a move to in vivo, prior to moving forward? This is definately not a bad thing should it happen, although I hazzard to state that maybe the general market consensus would not be good, at least in the wake of the announcement.

My key factors though are still the following,

- Executive appointment, why spend the cash if you are on a loser.
- Several years of product development already under the belt.
- Multiple international partners involved, or interested.
- The distinct lack of detailed information available through potential partner sites, through scientific and medical channels (usually a good sign)

Have had my sister who is a Phd in the biotech field also go through the researching of it, and that has also given me another reason to hold.

Hang in their guys, and to the downrampgers, if you don't like what you see, then it's actually quite an easy option......sell! I'll take them off your hands :-)